Credits: Canva
The world that we live in is filled with sounds, some are comforting and some could be jarring too. But what if the constant noise surrounding us is doing us more harm than we realize? There has been immense research that shows that noise is not just a nuisance, but a silent killer and affects our health in ways we do not even know. There are associations of sound causing heart attacks, type 2 diabetes, and dementia.
Noise is seen as an annoyance, but it effects can go beyond what we imagine. When we hear a sound, it travels through the ear to the brain. This is where it gets processed by the amygdala. It is a region that is responsible for emotional responses. This also triggers a stress response- our heart rate increases, our blood pressure rises, and stress hormones like cortisol flood our system.
This response is also designed to help us react to immediate threats. Especially, if we hear the sound of a predator approaching. However, when we are exposed to constant noise, this response is triggered repeatedly and could compel us to live in a long-term anxious state.
Many studies including Harvard Health and theAmerican College of Cardiology have found associations of noise with health problems including putting a person at a higher risk of cardiovascular diseases such as heart strokes, attacks, and high blood pressure. The constant activation of the stress response can take a toll on the body, increasing inflammation and making it harder for the heart and circulatory system to function properly. Over time, this can lead to serious health conditions like heart disease and diabetes.
Even more troubling, research suggests that noise pollution may contribute to mental health issues. Studies have found a strong connection between exposure to noise and disturbed sleep, which in turn can cause anxiety, depression, and cognitive decline. The World Health Organization estimates that noise contributes to around 12,000 premature deaths annually across Europe alone. This invisible threat, however, is often overlooked because the effects are gradual and cumulative.
One of the most insidious aspects of noise pollution is its impact on sleep. Even when we are asleep, our bodies are not fully immune to the effects of sound. Our ears never fully “turn off,” meaning that even faint noises can disrupt our sleep cycle. Research has shown that people who live in noisy environments—whether near busy roads, airports, or urban centers—often experience fragmented sleep, leading to fatigue and a weakened immune system. Over time, this chronic lack of restful sleep can lead to significant health problems, including an increased risk of developing cognitive disorders such as dementia.
As cities continue to grow, noise pollution is becoming more widespread. Traffic noise, in particular, is one of the most common and harmful sources. The rise of urbanization means more cars, buses, and trains, all of which contribute to an ever-increasing din. This urban soundscape is often relentless, with little respite for those living within it. In densely populated cities, people are exposed to high decibel levels, which can exceed safe thresholds for heart health. In many cases, the sheer volume of sound is not just unpleasant; it’s dangerous.
The solution is not as simple as reducing noise in our immediate surroundings, though efforts to reduce traffic noise and limit industrial sounds are essential. Some cities have taken steps to create quieter spaces by converting busy roads into pedestrian zones or installing noise barriers. These measures have shown to have a positive impact on public health, with research suggesting that even small reductions in noise can prevent premature deaths and improve overall well-being.
Credit: Canva
A two-year-old boy from Bristol, UK has died from a rare heart disease, known to mostly affect children with only flu-like symptoms, on January 8.
Hudson Martin had been diagnosed with Kawasaki disease when he was seven months old and was placed on lifelong medication including aspirin and blood thinners to reduce the risk of clots. Since then, he had been living a normal and happy life, according to father Damien Martin.
He told Bristol Live: "You’d never know anything was wrong from pictures or videos. He bounced off everything. He loved climbing, dancing, music, he was a proper daredevil."
But days before his third birthday, he suddenly collapsed while playing at home. Despite being given CPR by paramedics for an hour, his heart did not restart and he passed away.
“They did absolutely everything they could,” Damien said. "His heart just wouldn't come back."
Also known as mucocutaneous lymph node syndrome, Kawasaki disease causes inflammation in the walls of small to medium-sized blood vessels that carry blood throughout the body which can damage to the heart and blood vessels, mostly in children younger than five years old.
When this happens, the heart doesn't work as well to pump blood to the body and could burst (coronary artery dilation and aneurysms). It also causes swelling in the lymph nodes and mucous membranes inside the mouth, nose, eyes and throat.
Apart from a 102.2 degrees Fahrenheit (39 degrees Celsius) fever that can last for five days, children with Kawasaki may also experience some or all of the following symptoms:
It remains unknown what causes Kawasaki disease in children and if it affects adults.
Diagnosis involves ruling out other diseases that cause the same symptoms which include:
While this non-contagious disease can be treated with a mixture of antibodies given through the veins (intravenous immunoglobulin) and aspirin, it remains uncurable. Doctors may also advice steroids if intravenous immunoglobulin is not effective.
After receiving treatment for Kawasaki disease, most children recover fully and long-term follow-up care remains unnecessary. However, children who have suffered through aneurysms or other complications related to the disease will need lifelong monitoring with a cardiologist.
Credits: AI Generated
Cases of scabies, a highly contagious skin condition caused by microscopic mites, continue to remain higher than normal across England this winter, according to the latest surveillance data. Recent findings from the Royal College of General Practitioners’ Research and Surveillance Centre indicate that scabies has been spreading more widely than expected over the past few months, with infections steadily increasing through autumn and winter.
Overall, reported cases have stayed above the usual five-year average, with the sharpest rise recorded during the final four months of last year, particularly across northern regions of the country. With scabies infections continuing to climb, concerns are growing around which treatments are safe to use, especially when it comes to children.
Scabies is caused by a microscopic parasite known as Sarcoptes scabiei. This mite burrows into the top layer of the skin to lay its eggs, triggering severe itching and a red, spotty rash that often becomes more intense at night. Although the mites are too small to be seen easily, measuring less than half a millimetre, the body reacts to their saliva, eggs, and waste, leading to an allergic response.
Scabies spreads through prolonged skin-to-skin contact and can affect people of all ages. According to the NHS, it is most commonly transmitted through close household contact, including between partners, family members, people living together, and during sexual activity.
UK Health Security Agency surveillance data shows that scabies cases reported through sexual health services remained relatively stable before the COVID-19 pandemic, but numbers began rising sharply from 2022 onwards. Diagnoses increased from 3,393 cases in 2023 to 4,872 cases in 2024, marking a 44 per cent rise.
Both the UKHSA and the British Association for Sexual Health and HIV (BASHH) suggest several reasons could be driving the surge:
Experts also caution that the actual number of cases is likely much higher, as the available data only reflects diagnoses made in sexual health settings.
Ivermectin is an oral antiparasitic medicine used to treat scabies by paralysing the mites. It offers a systemic alternative to topical creams and is often considered in cases that are widespread, severe, or involve institutional outbreaks. Because the drug does not kill scabies eggs, a second dose is usually required after seven to fourteen days to target newly hatched mites.
According to the Centres for Disease Control and Prevention, ivermectin is generally well tolerated, improves treatment compliance compared to creams, and has been widely used in mass drug administration programmes, though repeat dosing is important due to its limited effect on mite eggs.
Despite its broad use in programmes targeting conditions such as river blindness, intestinal worms, and scabies, ivermectin has traditionally not been recommended for children weighing under 15 kilograms, largely due to limited safety data. However, researchers revisited this concern following a systematic review and meta-analysis that suggested the drug could be safe even in children weighing as little as 11 pounds.
In a double-blind clinical trial, researchers assessed the safety, effectiveness, and pharmacokinetics of ivermectin in young children with scabies. A total of 240 children weighing between 11 pounds and under 33 pounds in The Gambia, Kenya, and Brazil were randomly assigned to receive ivermectin at doses of 200, 400, or 800 micrograms per kilogram alongside a placebo cream, or placebo tablets alongside permethrin cream. Blood samples were collected on days 0, 3, 7, 10, and 14 to monitor biochemical markers, drug levels, and blood health.
The findings showed that ivermectin was effective in treating scabies, with just one serious adverse event reported. This involved a temporary increase in liver enzymes, which returned to normal levels within 32 days. All other side effects possibly linked to the treatment were mild, resolved on their own, and were similar to those seen in children weighing more than 33 pounds.
“Outcomes from the Ivermectin Safety in Small Children trial will hopefully provide greater reassurance that ivermectin can be safely used in children weighing less than 15 kilograms,” said lead study author Kevin Kobylinski, PhD, an honorary visiting research fellow at the University of Oxford with the Mahidol Oxford Tropical Medicine Research Unit in Bangkok, in an ASTMH press release.
Credits: AI Generated
England is recording higher-than-normal scabies infections this winter. Health authorities have cautioned that the condition, caused by microscopic mites known as Sarcoptes scabiei that tunnel into the skin, spreads quickly through close physical contact and often leads to severe itching and irritation. Data from the Royal College of General Practitioners’ Research and Surveillance Centre shows scabies is circulating more widely than usual in England, with cases increasing through the autumn and winter months.
Also Read: Doctor Explains Why Weight Loss Drugs Like Ozempic Are Truly A Medical Breakthrough
Scabies is caused by the Sarcoptes scabiei mite. These tiny parasites burrow beneath the skin where they survive, feed and lay eggs. The presence of the mites triggers an allergic reaction in the skin, resulting in an itchy rash. Scabies passes easily from one person to another, particularly among people living in close quarters.
If one member of a household is infected, doctors usually advise checking and treating other family members and close contacts at the same time, according to the Cleveland Clinic.
Early signs of scabies include intense itching, which is often worse at night, along with a pimple-like rash, small blisters, and thin, irregular lines on the skin known as burrows. These symptoms commonly appear between the fingers, on the wrists, elbows, armpits, waist and genitals. According to the National Health Service, these reactions occur due to the body’s response to the mites and their eggs beneath the skin.
Symptoms do not usually appear straight away and may take three to six weeks after the initial infection to develop. However, people who have had scabies before may notice symptoms within a few days. Typical signs include severe night-time itching and small bumps, blisters or burrow-like tracks on areas such as the hands, wrists, elbows, nipples, genitals and waist.
In more severe cases, the skin may become thickened, rough and scaly. Among children and older adults, scabies can also affect the scalp, face or the soles of the feet.
Yes, scabies exists in several forms beyond the classic type. These include:
Scabies is usually treated successfully with prescribed medicated creams and lotions called scabicides, along with careful hygiene measures. To avoid reinfection, clothes, bedding and towels should be washed at high temperatures and tumble-dried or ironed. Items that cannot be washed should be sealed in a bag for at least three days, as the mites cannot survive without contact with human skin.
Professor Michael Marks, a professor of medicine at the London School of Hygiene and Tropical Medicine and former chair of the International Alliance for the Control of Scabies, said the rise in cases may be linked to delays in accessing medical care and gaps in identifying and treating close contacts, which can allow the infection to continue spreading.
© 2024 Bennett, Coleman & Company Limited